Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical)

人凝血酶原复合物（南岳生物制药）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical)
Drug Alias Name人凝血酶原复合物
ClassificationBiologics > Blood components
Mechanisms of ActionCoagulation factor VII modulatorsCoagulation factor X modulatorsCoagulation factor IX modulators +[4] 
TargetsCoagulation factor VIICoagulation factor XCoagulation factor IX +[4] 
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesHunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A